Cargando…
Repurposing existing drugs for COVID-19: an endocrinology perspective
BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a multi-systemic infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that has become a pandemic. Although its prevailing symptoms include anosmia, ageusia, dry couch, fever, shortness of brief, arthralgia, mya...
Autor principal: | Cadegiani, Flavio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523486/ https://www.ncbi.nlm.nih.gov/pubmed/32993622 http://dx.doi.org/10.1186/s12902-020-00626-0 |
Ejemplares similares
-
Editorial: New Perspectives on the Endocrinology of Physical Activity and Sport
por: Ackerman, Kathryn E., et al.
Publicado: (2021) -
Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020) -
Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020) -
MON-LB311 Clinical Guidelines for the Research on the Endocrinology of Physical Activity and Sport
por: Cadegiani, Flavio A, et al.
Publicado: (2020) -
Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)